Skip to main content

Research News

academics

 

Clinical research courses

  • Weight loss and blood glucose are early indicators of pancreatic cancer

    Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates.

  • mRNA COVID vaccine elevates cardiovascular risk, finds study

    A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis is reported in a new study in the American Journal of Preventive Medicine, published by Elsevier.

  • The origin-of-life molecule, a key to cancer research

    A study by researchers at the Biomedical Institute of Seville (IBIS) and the University of Seville, in collaboration with the Danish Cancer Society, revealed that inhibiting RNA synthesis after radiation therapy facilitates the death of tumour cells. The study has been published in the prestigious journal Nature Communications.

  • Antioxidant benefits of honey explored

    Citrus honey has an increased abundance of antioxidants in comparison to other standard types of honey, according to a new study by University of the West of Scotland (UWS).

    Antioxidants are chemicals that reduce or prevent the effects of free radicals: unstable molecules that can damage cells, causing illness, disease, and ageing.

  • Study overcomes the obstacles to treatment for colon cancer

    Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs. As a result, the five-year survival rate for those affected is still low. After succeeding in reproducing this resistance in the laboratory, a team from the University of Geneva (UNIGE) has found a way to overcome it.

  • Three-dose hepatitis B vaccine regimen protects people with HIV

    A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsors the ongoing Phase 3 ACTG A5379 clinical study.

  • Two drugs reverse key pancreatic cancer step in the lab

    Pancreatic cancer often lurks as a silent disease. With no known symptoms, it can progress undetected and spread to other organs.

    According to the National Cancer Institute, more than 60,000 Americans will be diagnosed with pancreatic cancer this year, and only about 1 in 10 of those diagnosed will survive the next five years.  The disease ranks as the third leading cause of cancer deaths in the U.S. because it is rarely detected in the early stages when treatment options are most effective.

  • Researchers find protein complex that regulates migration of neurons and neuroblastoma cancer cells

    During brain development, neurons have to migrate long distances through complex environments until they reach their final destination. In order to find guidance, they must establish several interactions —which are still hard to study— between their receptors and the surrounding molecules.

  • What will the future of the bioeconomy look like?

    The 2012 EU Bioeconomy Strategy is delivering on key actions and has seen a two-fold increase in EU R&I funding for the bioeconomy under Horizon 2020, today Horizon Europe.

  • Antisepsis Agents Interchangeable in Reducing Infection Risk in Open Fracture Surgeries

    Orthopaedics faculty at LSU Health New Orleans participated in a study comparing two antisepsis aqueous solutions in reducing the risk of infection in patients requiring surgery for open fractures. In the largest known randomized-controlled trial, the research team found that contrary to current international recommendations, chlorhexidine gluconate was not superior to povidone-iodine in an alcohol or aqueous solution in preventing surgical site infection.

Subscribe to Research News